Journal of Enzyme Inhibition and Medicinal Chemistry · 2019 · 26 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyEnzyme FunctionLigand BindingProtein StructureProtein-protein Interaction ModelingAntiproliferative AgentsAntiproliferative Drug ActionBinding Mode AnalysisHit ConfirmationNuclear Translocation Of Transcription FactorsProtein TargetsProtein-ligand Complex ModelingProtein-protein Interaction Inhibitor Discovery
14-3-3 are regulatory proteins that through protein-protein interactions (PPI) with numerous binding partners could be involved in several human diseases, including cancer, neurodegenerative disorders, and pathogens infections. Following our research interest in the development of 14-3-3 PPI inhibitors, here we exploited the privileged 4-aminoantipyrine scaffold in the design and synthesis of some derivatives endowed with antiproliferative activity against K-562 cells, and capable of binding to recombinant 14-3-3σ as evidenced by NMR spectroscopy. The binding mode was further explored by molecular modelling, while coupling confocal microscopy with intensitometric analysis showed that compound 1 was able to promote the nuclear translocation of c-Abl at low micromolar concentrations. Overall, 1 is chemically stable compared to parent 14-3-3 PPI inhibitors, and thus emerged as a confirmed hit for further development.
15
Improved protein–ligand docking using GOLD
Marcel L. Verdonk, Jason C. Cole, Michael J. Hartshorn et al. · Proteins Structure Function and Bioinformatics · 2003 · 3K citations · Full text
Tohru Ichimura, Toshiaki Isobe, Tsuneo Okuyama et al. · Proceedings of the National Academy of Sciences · 1988 · 339 citations · Full text
A Structural Basis for 14-3-3σ Functional Specificity*♦
Erik Wilker, Robert A. Grant, Stephen C. Artim et al. · Journal of Biological Chemistry · 2005 · 238 citations · Full text